Studies on the Interaction between Collagen and a Plasma Kallikrein-Like Activity EVIDENCE FOR A SURFACE-ACTIVE ENZYME SYSTEM
- 1 July 1972
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 51 (7) , 1813-1822
- https://doi.org/10.1172/jci106983
Abstract
This study has demonstrated that collagen particles, after exposure to platelet-poor human plasma and subsequent washing, generate a kinin-like agent when incubated with prekinin substrate. The binding of kinin-generating activity to collagen in the plasma collagen incubation mixture occurs rapidly, whereas the loss of this activity in the incubation mixture occurs relatively slowly. The Hageman factor appeared to be necessary for the surface-bound kinin-generating activity, as this activity was absent in collagen exposed to Hageman factor-deficient plasma. These studies have partially characterized the plasma-derived enzymatic activity bound to collagen. Incubation of collagen with plasma caused a concentration-dependent reduction in the kinin-producing activity which was generated by the addition of ellagic acid, a known activator of plasma kallikrein. The kinin-inducing activity bound to collagen is inhibited by soybean trypsin inhibitor, Trasylol, serum C1̄ inactivator and the plasma α2-macroglobulin, but not by lima bean trypsin inhibitor. An eluate prepared from plasma-treated collagen, when compared with purified plasma kallikrein, shared a similar inhibitor profile. Selective chemical blockage of the free carboxyl groups on the collagen molecule, or heat denaturation, inactivated the ability of the collagen to generate kinin-like activity after incubation with plasma. Removal of the collagen telopeptides or blockage of the free amino groups failed to affect the collagen-plasma interaction. The binding of partially purified plasma kallikrein to collagen was found to have similar structural and chemical requirements. These data indicate that there is a structural and chemical specificity for the activation and binding of plasma kallikrein-like activity by collagen. These studies suggest that a plasma kallikrein may function as a surface-bound enzyme system.Keywords
This publication has 35 references indexed in Scilit:
- Separation of Plasma Thromboplastin Antecedent from Kallikrein by the Plasma α2-Macroglobulin, Kallikrein InhibitorJournal of Clinical Investigation, 1971
- Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.1970
- THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITORThe Journal of Experimental Medicine, 1969
- Aggregation of platelets by collagenJournal of Clinical Investigation, 1968
- Effect of inhibitors on kinin-releasing activity of proteases.1968
- The biology and pathology of the initial stages of blood coagulation.1966
- Adsorption of hageman factor (factor XII) on collagenCellular and Molecular Life Sciences, 1964
- ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.1964
- Action of the Kallikreins on Synthetic Ester SubstratesExperimental Biology and Medicine, 1961
- ENZYME-LIKE GLOBULINS FROM SERUM REPRODUCING THE VASCULAR PHENOMENA OF INFLAMMATION .5. ACTIVABLE PERMEABILITY FACTOR IN HUMAN SERUM1958